About Source BioScience
Source BioScience is a company based in Nottingham (United Kingdom) founded in 1903 was acquired by Qualitas Funds in December 2023. Source BioScience has completed 3 acquisitions, including Camclinlabs, ImaGenes and Vindon. Source BioScience offers products and services including Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing. Source BioScience operates in a competitive market with competitors including Horizon Discovery, Quanterix, Arrakis Therapeutics, NanoString and Rejuvenate Bio, among others.
- Headquarter Nottingham, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Source Bioscience Limited
- Date of Incorporation 14 Nov, 1903
- Jurisdiction NOTTINGHAM, NOTTINGHAMSHIRE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$41.38 M (USD), Post-IPO
Oct 27, 2020
-
Investors
Qualitas Funds
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Camclinlabs
& 2 more
-
Acquired by
Qualitas Funds
(Dec 09, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Source BioScience
Source BioScience offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing.
Service for sequencing entire genomes in research and clinical trials.
Tests for identifying genetic indications in healthcare settings.
Laboratory analysis for tissue samples in medical diagnostics.
Rapid sequencing method for DNA and RNA applications.
Traditional method for accurate DNA sequencing tasks.
People of Source BioScience
Unlock access to complete
Funding Insights of Source BioScience
Investors in Source BioScience
Source BioScience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Qualitas Funds and Harwood Private Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Harwood Private Equity is focused on UK mid-market investments.
|
Locked | Locked | Locked | |
|
Fund of funds focused on lower mid-market investments
|
Locked | Locked | Locked |
Investor details for Source BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Source BioScience
Source BioScience has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Camclinlabs, ImaGenes and Vindon.
Investment portfolio details for Source BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genome research services, including gene cloning and profiling, are provided.
|
Locked | Locked | 2007 | Locked | |
|
Personalized healthcare testing services in oncology and virology are provided.
|
Locked | Locked | 0 | Locked | |
|
-
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Source BioScience
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Source BioScience
Detailed financials for Source BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Source Bioscience Comparisons
Peer comparison for Source BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Source BioScience
Source BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Discovery, Quanterix, Arrakis Therapeutics, NanoString and Rejuvenate Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetically modified cell lines are developed using AAV gene-editing platform.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Provider of tools for the analysis of RNA structures
|
|
| Locked | Locked | Locked |
Tools for translational research and molecular diagnosis are developed.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
Detailed competitors of Source BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Source Bioscience
Complete news archive for Source BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Source BioScience
Source BioScience was founded in 1903 and raised its 1st funding round 113 years after it was founded.
Source BioScience is headquartered in Nottingham, United Kingdom.
Jay LeCoque is the current CEO of Source BioScience.
Source BioScience was founded in 1903 in Nottingham, United Kingdom. Operations focus on the genomics sector, where genetic analysis and clinical diagnostics for research are conducted. Genome analysis, controlled environment storage, proteomics, drug discovery, and analytical testing are included in the services. Antibodies, assays, kits, and reagents are supplied, alongside reference laboratory testing for cancer and other diseases.
Source BioScience's top competitors include Horizon Discovery, Novogene Corporation and NanoString.
Source BioScience offers Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing.
Source BioScience has made 3 acquisitions, including Camclinlabs, ImaGenes, and Vindon.
Source BioScience has 2 investors. Key investors include Qualitas Funds, and Harwood Private Equity.